John H. Strickler

Also affiliated with Cancer Institute (WIA), Duke Medical Center, Duke Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial”.

Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial

Nature Medicine(2024)10.1038/s41591-023-02717-6

N/A

2.0DataRank · unranked

94 citations

Marwan Fakih, John H. Strickler, Rona Yaeger, Toshiki Masuishi, Edward Kim +14 more

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

Cell Reports(2021)10.1016/j.celrep.2021.109071

N/A

0.666DataRank · unranked

84 citations

Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K.S. Salama +6 more

A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations

The Oncologist(2025)10.1093/oncolo/oyaf069

N/A

0.232DataRank · unranked

3 citations

Tyler Zemla, Joleen M. Hubbard, John H. Strickler, Olumide B. Gbolahan, L. R. Wilson +6 more

A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer

Journal of Gastrointestinal Cancer(2024)10.1007/s12029-024-01156-x

N/A

0.227DataRank · unranked

3 citations

Ashley Moyer, Melissa Lowe, Emily Bolch, Jeremy Kortmansky, May Cho +5 more

Management of Microsatellite Instability High (MSI-H) Gastroesophageal Adenocarcinoma

Journal of Gastrointestinal Cancer(2023)10.1007/s12029-023-01003-5

N/A

0DataRank · unranked

8 citations

Brent A. Hanks, John H. Strickler, Katherine I. Zhou

Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice

Hematology Reports(2024)10.3390/hematolrep16040059

N/A

0DataRank · unranked

0 citations

Katherine I. Zhou, Michelle Green, Bennett Adam Caughey, John H. Strickler, Michael Datto +2 more

A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2024)10.17615/yy24-c083

N/A

0DataRank · unranked

0 citations

Jingquan Jia, Aparna Kalyan, Emily Bolch, May Cho, Melissa Lowe +5 more

918O Telisotuzumab adizutecan (ABBV-400; Temab-A) in patients with MET-amplified (MET-amp) advanced solid tumors: Results from a phase I study

Annals of Oncology(2025)10.1016/j.annonc.2025.08.1487

N/A

0DataRank · unranked

2 citations

Yasutoshi Kuboki, John H. Strickler, Kanwal Pratap Singh Raghav, Antoine Hollebecque, D.H. Lee +15 more

A phase II study of savolitinib (volitinib, AZD6094, HMPL-504) in subjects with MET amplified metastatic colorectal cancer (mCRC) detected by cell-free (cf)DNA.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.tps270

N/A

0DataRank · unranked

3 citations

Donna Niedzwiecki, Christy Arrowood, Nancy Garett-Mead, Rebecca J. Nagy, Richard B. Lanman +4 more

Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Suppressing MHC Class I Expression

medRxiv(2025)10.1101/2025.10.06.25337175

N/A

0DataRank · unranked

0 citations

Nagendra Sastry Yarla, Kaylee Villareal, Y‐Van Nguyen, Linda Cao, Ernesto Pena Calderin +9 more

Frequency of practice-changing findings identified by comprehensive genomic profiling in non-myeloid hematologic malignancies.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3060

N/A

0DataRank · unranked

0 citations

Chenyu Lin, Michelle Green, Bennett Adam Caughey, Michael Datto, John H. Strickler +2 more

Clinical outcomes of immune checkpoint inhibitor (ICI) therapy among Veterans Affairs patients with colorectal cancer and discordant dMMR/MSI-H status.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3534

N/A

0DataRank · unranked

0 citations

Aixia Guo, Vishal Vashistha, Evangelia Katsoulakis, Elizabeth Boswell, John H. Strickler +3 more

Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers

Annals of Surgical Oncology(2023)10.1245/s10434-023-13567-4

N/A

0DataRank · unranked

10 citations

Annie Liu, Alex J. Bartholomew, Ryan J. Kramer, Anika Parameswaran, Hope E. Uronis +10 more